Metabolic

Incretin, mitochondrial and melanocortin compounds studied in metabolic signalling research.

The incretin compounds here — Tirzepatide, a dual GIP and GLP-1 receptor agonist, and Retatrutide, which adds glucagon receptor activity — are the subject of the most active regulatory attention in the field, covered regularly in our briefings. MOTS-c is mitochondria-encoded and studied in metabolic homeostasis. PT-141 and Melanotan 2 act at melanocortin receptors, a separate pathway grouped here for convenience rather than mechanism. AOD9604 is a fragment of the C-terminal region of growth hormone, studied for activity on lipid metabolism separately from the growth-promoting action of the whole molecule.

Choosing a size. The larger Retatrutide and Tirzepatide vials cost materially less per milligram; the smaller ones suit shorter protocols where reconstituted stability is the constraint.